Jamil Khurram

Chief Medical OfficerGALECTIN THERAPEUTICS INC (GALT) · full profile →Form 4 · filed Jun 30, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$262K
Net Open-Market Flow
-$262K
Transactions
9
6 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 29, 2026Option exercise(M)47K$2.50$119K47K
Jun 29, 2026Sell(S)47K$5.04$239K0
Jun 26, 2026Option exercise(M)3K$2.50$6K3K
Jun 26, 2026Sell(S)3K$5.00$13K0
Jun 26, 2026Option exercise(M)2K$2.20$4K2K
Jun 26, 2026Sell(S)2K$5.00$10K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 29, 2026Option exercise(M)47K$00
Jun 26, 2026Option exercise(M)2K$0100K
Jun 26, 2026Option exercise(M)3K$047K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001133416-26-000059) within minutes of acceptance. Every field above traces to the original document. Verify it directly: